DE69230361T2 - Direkter Nachweis der RNS des Hepatitis-C-Virus - Google Patents

Direkter Nachweis der RNS des Hepatitis-C-Virus

Info

Publication number
DE69230361T2
DE69230361T2 DE69230361T DE69230361T DE69230361T2 DE 69230361 T2 DE69230361 T2 DE 69230361T2 DE 69230361 T DE69230361 T DE 69230361T DE 69230361 T DE69230361 T DE 69230361T DE 69230361 T2 DE69230361 T2 DE 69230361T2
Authority
DE
Germany
Prior art keywords
hepatitis
rna
virus
direct detection
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230361T
Other languages
English (en)
Other versions
DE69230361D1 (de
Inventor
John M Vierling
Ke-Qin Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25053384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69230361(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of DE69230361D1 publication Critical patent/DE69230361D1/de
Publication of DE69230361T2 publication Critical patent/DE69230361T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69230361T 1991-09-12 1992-09-09 Direkter Nachweis der RNS des Hepatitis-C-Virus Expired - Fee Related DE69230361T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75886291A 1991-09-12 1991-09-12

Publications (2)

Publication Number Publication Date
DE69230361D1 DE69230361D1 (de) 2000-01-05
DE69230361T2 true DE69230361T2 (de) 2000-04-20

Family

ID=25053384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230361T Expired - Fee Related DE69230361T2 (de) 1991-09-12 1992-09-09 Direkter Nachweis der RNS des Hepatitis-C-Virus

Country Status (10)

Country Link
US (1) US5914228A (de)
EP (1) EP0531974B2 (de)
JP (1) JPH06502770A (de)
AT (1) ATE187204T1 (de)
AU (1) AU665204B2 (de)
CA (1) CA2077519A1 (de)
DE (1) DE69230361T2 (de)
ES (1) ES2141094T3 (de)
MX (1) MX9205203A (de)
WO (1) WO1993005181A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
ES2133529T3 (es) 1992-11-27 1999-09-16 Innogenetics Nv Procedimiento para tipificar aislamientos de hcv.
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
WO2003004686A2 (en) * 2001-07-03 2003-01-16 Advanced Dna Technologies, Inc. Fluorescence-based assay for the detection of specific nucleic acids using photon counting
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
JP4733936B2 (ja) * 2004-07-08 2011-07-27 大陽日酸株式会社 Ｒｎａ追跡方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562159A (en) * 1981-03-31 1985-12-31 Albert Einstein College Of Medicine, A Division Of Yeshiva Univ. Diagnostic test for hepatitis B virus
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
RO113059B1 (ro) * 1989-05-18 1998-03-30 Chiron Corp Polinucleotida capabila de hibridizare pe o secventa hcv, metoda pentru detectarea unei secvente hcv si procedeu de eliminare a hcv din sange
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0461863A1 (de) * 1990-06-12 1991-12-18 Immuno Japan Inc. Oligonukleotid-Primer und ihre Anwendung zum Nachweis von non-A, non-B-Hepatitisvirus mit grosser Genauigkeit

Also Published As

Publication number Publication date
AU2283792A (en) 1993-03-25
AU665204B2 (en) 1995-12-21
US5914228A (en) 1999-06-22
ES2141094T3 (es) 2000-03-16
ATE187204T1 (de) 1999-12-15
MX9205203A (es) 1993-04-01
EP0531974A1 (de) 1993-03-17
CA2077519A1 (en) 1993-03-13
WO1993005181A1 (en) 1993-03-18
DE69230361D1 (de) 2000-01-05
EP0531974B1 (de) 1999-12-01
JPH06502770A (ja) 1994-03-31
EP0531974B2 (de) 2004-11-10

Similar Documents

Publication Publication Date Title
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
DE3853678T2 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
ATE326701T1 (de) Vorrichtung zur behandlung von blutproben
DE3484832D1 (de) Nachweis von bakterien mittels nukleinsaeuren-hybridisation, markierte sonden und testsatz dafuer.
NO20000536D0 (no) Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
DK430384A (da) Fremgangsmaade til paavisning, identificering og kvantitativ bestemmelse af organismer og virus
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
DE69230361D1 (de) Direkter Nachweis der RNS des Hepatitis-C-Virus
DK0991421T3 (da) Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom
DE69033067D1 (de) 4,7-dichlorfluoreszein-farbstoffe als molekulare sonden
BR9405334A (pt) Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico
DE3576853D1 (de) Ultraschall-koagulationsanzeiger und methode zum nachweis des eintretens von koagulation.
ATE318934T1 (de) Verfahren zum nachweis von ki-ras mutationen
DE60027045D1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
DE3767042D1 (de) Messvorrichtung zur intrakardialen erfassung der blutsauerstoffsaettigung.
DE69432043D1 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
ATE229571T1 (de) Nachweis und identifizierung von nicht-polio enteroviren
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
TR200100689T1 (tr) Anti-hepatit B ilacının direncinin saptanması
SE9002930D0 (sv) Foerfarande och anordning foer amperometrisk diagnostisk analys
DE59813486D1 (de) Verfahren zur Herstellung von Blutplasmaprodukten durch Ausschluss von Spenden mit hohen Parvo-B19-Virenkonzentrationen
FR2655835B1 (fr) Appareil de detection de kystes et/ou tumeurs du sein.
DE69026868D1 (de) DNS-Probe zum Nachweis vom Human-Parainfluenza-Typ-2-Virus
Ye et al. Rapid detection of adenovirus and rotavirus in stools from infants with diarrhea by polyacrylamide gel electrophoresis.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee